Literature DB >> 4026796

Cysteamine depletes cystinotic leucocyte granular fractions of cystine by the mechanism of disulphide interchange.

W A Gahl, F Tietze, J D Butler, J D Schulman.   

Abstract

Cystinotic lysosome-rich leucocyte granular fractions, loaded with [35S]cystine, were exposed to different cystine-depleting agents. During a 30 min incubation at 37 degrees C, untreated cystinotic granular fractions lost negligible [35S]cystine when corrected for lysosome rupture. Granular fractions exposed to 0.1 mM-cysteamine lost 64% of their initial cystine, and hexosaminidase activity was decreased by 10%. This was accompanied by the formation of high concentrations of [35S]cysteine-cysteamine mixed disulphide within the granular-fraction pellet, and, in the presence of N-ethylmaleimide, increasing amounts of [35S]cysteine-N-ethylmaleimide adduct outside the granular fraction. In separate experiments, [35S]cystine exited cystinotic leucocyte lysosomes at a negligible rate (half-times 199 and 293 min), but [35S]cysteine-cysteamine mixed disulphide exhibited substantial egress (half-times 66 and 88 min) and was recovered intact outside the granular-fraction pellet. We conclude that cysteamine depletes lysosomes of cystine by participating in a thiol-disulphide interchange reaction to produce cysteine and cysteine-cysteamine mixed disulphide, both of which traverse the cystinotic leucocyte lysosomal membrane.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4026796      PMCID: PMC1145021          DOI: 10.1042/bj2280545

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  11 in total

1.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

2.  Cystinosis. Intracellular cystine depletion by aminothiols in vitro and in vivo.

Authors:  J G Thoene; R G Oshima; J C Crawhall; D L Olson; J A Schneider
Journal:  J Clin Invest       Date:  1976-07       Impact factor: 14.808

3.  Use of dithiothreitol to correct cystine storage in cultured cystinotic fibroblasts.

Authors:  H Goldman; C R Scriver; K Aaron; L Pinsky
Journal:  Lancet       Date:  1970-04-18       Impact factor: 79.321

4.  Defective cystine exodus from isolated lysosome-rich fractions of cystinotic leucocytes.

Authors:  W A Gahl; F Tietze; N Bashan; R Steinherz; J D Schulman
Journal:  J Biol Chem       Date:  1982-08-25       Impact factor: 5.157

5.  Ineffectiveness of ascorbic acid therapy in nephropathic cystinosis.

Authors:  J A Schneider; J J Schlesselman; S A Mendoza; S Orloff; J G Thoene; W A Kroll; A D Godfrey; J D Schulman
Journal:  N Engl J Med       Date:  1979-04-05       Impact factor: 91.245

6.  Decrease in free cystine content of cultured cystinotic fibroblasts by ascorbic acid.

Authors:  W A Kroll; J A Schneider
Journal:  Science       Date:  1974-12-13       Impact factor: 47.728

7.  Cystine transport is defective in isolated leukocyte lysosomes from patients with cystinosis.

Authors:  W A Gahl; N Bashan; F Tietze; I Bernardini; J D Schulman
Journal:  Science       Date:  1982-09-24       Impact factor: 47.728

8.  Characteristics of cystine counter-transport in normal and cystinotic lysosome-rich leucocyte granular fractions.

Authors:  W A Gahl; F Tietze; N Bashan; I Bernardini; D Raiford; J D Schulman
Journal:  Biochem J       Date:  1983-11-15       Impact factor: 3.857

9.  Patterns of amino acid efflux from isolated normal and cystinotic human leucocyte lysosomes.

Authors:  R Steinherz; F Tietze; D Raiford; W A Gahl; J D Schulman
Journal:  J Biol Chem       Date:  1982-06-10       Impact factor: 5.157

10.  The metabolism of amino acids, peptides, and disulfides in lysosomes of fibroblasts cultured from normal individuals and those with cystinosis.

Authors:  J D Schulman; K H Bradley
Journal:  J Exp Med       Date:  1970-12-01       Impact factor: 14.307

View more
  23 in total

1.  Effects of oral phosphocysteamine and rectal cysteamine in cystinosis.

Authors:  W G van't Hoff; T Baker; R N Dalton; L C Duke; S P Smith; C Chantler; G B Haycock
Journal:  Arch Dis Child       Date:  1991-12       Impact factor: 3.791

2.  Predicted reciprocal serum creatinine at age 10 years as a measure of renal function in children with nephropathic cystinosis treated with oral cysteamine.

Authors:  W A Gahl; J A Schneider; J D Schulman; J G Thoene; G F Reed
Journal:  Pediatr Nephrol       Date:  1990-03       Impact factor: 3.714

3.  Cysteamine, the natural metabolite of pantetheinase, shows specific activity against Plasmodium.

Authors:  Gundula Min-Oo; Kodjo Ayi; Silayuv E Bongfen; Mifong Tam; Irena Radovanovic; Susan Gauthier; Helton Santiago; Antonio Gigliotti Rothfuchs; Ester Roffê; Alan Sher; Alaka Mullick; Anny Fortin; Mary M Stevenson; Kevin C Kain; Philippe Gros
Journal:  Exp Parasitol       Date:  2010-02-26       Impact factor: 2.011

4.  The aminoglycoside geneticin permits translational readthrough of the CTNS W138X nonsense mutation in fibroblasts from patients with nephropathic cystinosis.

Authors:  Emma J Brasell; LeeLee Chu; Reyhan El Kares; Jung Hwa Seo; Robin Loesch; Diana M Iglesias; Paul Goodyer
Journal:  Pediatr Nephrol       Date:  2018-11-09       Impact factor: 3.714

5.  Cystinosis: renal glomerular and renal tubular function in relation to compliance with cystine-depleting therapy.

Authors:  Galina Nesterova; Caitlyn Williams; Isa Bernardini; William A Gahl
Journal:  Pediatr Nephrol       Date:  2014-12-20       Impact factor: 3.714

6.  Effect of Storage Conditions on Stability of Ophthalmological Compounded Cysteamine Eye Drops.

Authors:  Ahmed Reda; Ann Van Schepdael; Erwin Adams; Prasanta Paul; David Devolder; Mohamed A Elmonem; Koenraad Veys; Ingele Casteels; Lambertus van den Heuvel; Elena Levtchenko
Journal:  JIMD Rep       Date:  2017-12-07

Review 7.  C. elegans as a model for membrane traffic.

Authors:  Ken Sato; Anne Norris; Miyuki Sato; Barth D Grant
Journal:  WormBook       Date:  2014-04-25

8.  CTNS mutations in an American-based population of cystinosis patients.

Authors:  V Shotelersuk; D Larson; Y Anikster; G McDowell; R Lemons; I Bernardini; J Guo; J Thoene; W A Gahl
Journal:  Am J Hum Genet       Date:  1998-11       Impact factor: 11.025

Review 9.  Nephropathic cystinosis: late complications of a multisystemic disease.

Authors:  Galina Nesterova; William Gahl
Journal:  Pediatr Nephrol       Date:  2008-06       Impact factor: 3.714

10.  Disulphide reduction in lysosomes. The role of cysteine.

Authors:  J B Lloyd
Journal:  Biochem J       Date:  1986-07-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.